RE:another fine day Why would you ask whether BBB is dead, Rosie1965? Bioasis has made no such statement. Instead, they've acquired a new technology so they can call themselves a clinical-stage biotech, I assume because they need that to move forward with financings from more sophisticated investors and a move to Nasdaq.
In the last few months we've had new BBB deals made with J&J/Janssen and Neuramedy added to the rest of that now long list of partners. I trust their opinions about xB3 way over my own and certainly uninformed posters on here.
I understand people getting upset with the share price, but people are abandoning their reason. What it means is that Finallytherock is winning the argument on this forum. He can have it, although I will deal with lies that scare people. But it all makes little difference to me. In fact, it's to my benefit because I want a lot of stock and will be chasing that goal by all means at my disposal.
I'll stick with the opinions being expressed by Bioasis partners who are expressing those opinions by putting money on the line to work with xB3.
Silly stuff on here.
jd